PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28827662-0	2017	Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis.	isoliquiritigenin	0-17	microRNA 374a	Homo sapiens	28-36	
32296334-0	2020	Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development.	isoliquiritigenin	0-17	microRNA 374a	Homo sapiens	39-47	
28827662-6	2017	We also verified the anti-cancer effect of isoliquiritigenin on migration and invasion, and identified highly expressed miR-374a as one of the main microRNAs down-regulated by isoliquiritigenin treatment in breast cancer.	isoliquiritigenin	176-193	microRNA 374a	Homo sapiens	120-128	
28827662-7	2017	Further study displayed that isoliquiritigenin increased PTEN expression through the decrease of miR-374a expression to inhibit the aberrant Akt signaling.	isoliquiritigenin	29-46	microRNA 374a	Homo sapiens	97-105	
28827662-8	2017	Our findings suggest isoliquiritigenin as a novel anti-cancer candidate significantly regulating miR-374a/PTEN/Akt axis in microRNA-based breast cancer therapies.	isoliquiritigenin	21-38	microRNA 374a	Homo sapiens	97-105